Par Drugs and Chemicals Limited(IN:PAR)
₹115.54-3.46 (-2.91%)
IN:PAR
Par Drugs and Chemicals Limited financials statements
₹115.54
At close:-3.46 (-2.91%)
Want to see IN:PAR full AI Analyst Report?
Par Drugs and Chemicals Limited (PAR) Ratios
1 Followers
Par Drugs and Chemicals Limited Ratios
IN:PAR's free cash flow for Q2 2027 was ₹0.00. For the 2027 fiscal year, IN:PAR's free cash flow was increased by ₹0.00 and operating cash flow was ₹0.00. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 4.68 | 3.31 | 4.79 | 3.53 | 2.93 |
| Quick Ratio | 4.29 | 2.94 | 4.44 | 3.11 | 2.56 |
| Cash Ratio | 3.04 | 1.66 | 2.95 | 1.59 | 1.09 |
| Solvency Ratio | 0.98 | 0.83 | 1.12 | 0.83 | 0.66 |
| Operating Cash Flow Ratio | 1.20 | 0.98 | 1.63 | 0.96 | 0.51 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | ₹ 470.98M | ₹ 344.46M | ₹ 436.44M | ₹ 318.07M | ₹ 247.51M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.15 | 1.21 | 1.19 | 1.25 | 1.31 |
| Debt Service Coverage Ratio | 133.07 | 181.93 | 167.48 | 110.36 | 28.34 |
| Interest Coverage Ratio | 105.48 | 195.18 | 515.02 | 109.29 | 27.86 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.10 | 0.07 | 0.09 | 0.11 | 0.37 |
| Net Debt to EBITDA | -1.98 | -1.41 | -1.60 | -1.21 | -0.99 |
| Profitability Margins | |||||
| Gross Profit Margin | 48.69% | 61.19% | 63.77% | 30.17% | 32.62% |
| EBIT Margin | 16.81% | 15.87% | 20.41% | 16.00% | 17.53% |
| EBITDA Margin | 20.39% | 19.31% | 24.00% | 19.40% | 21.93% |
| Operating Profit Margin | 12.95% | 15.87% | 57.67% | 15.31% | 16.96% |
| Pretax Profit Margin | 16.69% | 17.75% | 20.41% | 15.86% | 17.03% |
| Net Profit Margin | 12.65% | 13.23% | 15.16% | 11.92% | 12.35% |
| Continuous Operations Profit Margin | 12.65% | 13.23% | 15.16% | 11.92% | 12.35% |
| Net Income Per EBT | 75.77% | 74.53% | 74.30% | 75.16% | 72.53% |
| EBT Per EBIT | 128.85% | 111.85% | 35.38% | 103.59% | 100.38% |
| Return on Assets (ROA) | 10.15% | 11.19% | 14.27% | 12.75% | 11.71% |
| Return on Equity (ROE) | 11.71% | 13.50% | 16.93% | 15.91% | 15.39% |
| Return on Capital Employed (ROCE) | 11.63% | 15.58% | 61.86% | 19.44% | 19.83% |
| Return on Invested Capital (ROIC) | 8.81% | 11.62% | 45.96% | 14.61% | 14.38% |
| Return on Tangible Assets | 10.15% | 11.19% | 14.27% | 12.74% | 11.69% |
| Earnings Yield | 13.55% | 12.53% | 5.32% | 6.58% | 4.69% |
| Efficiency Ratios | |||||
| Receivables Turnover | 8.54 | 6.01 | 6.93 | 5.58 | 4.01 |
| Payables Turnover | 6.49 | 3.60 | 6.47 | 8.21 | 4.68 |
| Inventory Turnover | 9.90 | 6.42 | 7.84 | 11.13 | 9.07 |
| Fixed Asset Turnover | 2.79 | 2.59 | 2.31 | 2.46 | 2.17 |
| Asset Turnover | 0.80 | 0.85 | 0.94 | 1.07 | 0.95 |
| Working Capital Turnover Ratio | 2.33 | 2.36 | 2.31 | 2.96 | 2.77 |
| Cash Conversion Cycle | 23.38 | 16.20 | 42.85 | 53.75 | 53.15 |
| Days of Sales Outstanding | 42.74 | 60.78 | 52.70 | 65.42 | 90.94 |
| Days of Inventory Outstanding | 36.87 | 56.87 | 46.57 | 32.80 | 40.25 |
| Days of Payables Outstanding | 56.23 | 101.44 | 56.42 | 44.48 | 78.04 |
| Operating Cycle | 79.62 | 117.65 | 99.27 | 98.23 | 131.19 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 13.35 | 13.14 | 16.45 | 10.87 | 6.19 |
| Free Cash Flow Per Share | 11.76 | 12.14 | 11.51 | 4.67 | 3.59 |
| Dividend Paid and CapEx Coverage Ratio | 8.38 | 13.17 | 3.33 | 1.75 | 1.61 |
| Capital Expenditure Coverage Ratio | 8.38 | 13.17 | 3.33 | 1.75 | 2.38 |
| Operating Cash Flow Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cash Flow to Sales Ratio | 0.16 | 0.16 | 0.21 | 0.14 | 0.10 |
| Free Cash Flow Yield | 14.96% | 14.01% | 5.20% | 3.33% | 2.24% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 7.38 | 7.98 | 18.79 | 15.20 | 21.34 |
| Price-to-Sales (P/S) Ratio | 0.93 | 1.06 | 2.85 | 1.81 | 2.63 |
| Price-to-Book (P/B) Ratio | 0.86 | 1.08 | 3.18 | 2.42 | 3.28 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 6.68 | 7.14 | 19.23 | 29.99 | 44.54 |
| Price-to-Operating Cash Flow Ratio | 5.89 | 6.60 | 13.45 | 12.88 | 25.81 |
| Price-to-Earnings Growth (PEG) Ratio | -3.82 | -1.02 | 0.67 | 0.66 | -1.03 |
| Enterprise Value Multiple | 2.60 | 4.05 | 10.27 | 8.13 | 11.02 |
| Enterprise Value | 548.81M | 790.39M | 2.36B | 1.50B | 1.80B |
| EV to EBITDA | 2.60 | 4.05 | 10.27 | 8.13 | 11.02 |
| EV to Sales | 0.53 | 0.78 | 2.47 | 1.58 | 2.42 |
| EV to Free Cash Flow | 3.79 | 5.29 | 16.64 | 26.12 | 40.87 |
| EV to Operating Cash Flow | 3.34 | 4.89 | 11.64 | 11.21 | 23.68 |
| Tangible Book Value Per Share | 90.98 | 80.47 | 69.56 | 57.90 | 48.66 |
| Shareholders’ Equity Per Share | 90.98 | 80.47 | 69.56 | 57.90 | 48.66 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.24 | 0.25 | 0.26 | 0.25 | 0.27 |
| Revenue Per Share | 84.21 | 82.09 | 77.69 | 77.28 | 60.64 |
| Net Income Per Share | 10.65 | 10.86 | 11.78 | 9.21 | 7.49 |
| Tax Burden | 0.76 | 0.75 | 0.74 | 0.75 | 0.73 |
| Interest Burden | 0.99 | 1.12 | 1.00 | 0.99 | 0.97 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.36 | 0.06 | 0.02 | 0.01 | 0.02 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 1.25 | 1.21 | 1.40 | 0.89 | 0.60 |
Currency in INR

